is compounding tirzepatide going away September 2, 2025: U.S. restrictions have stemmed a flood of compounded semaglutide and – Partnership for Safe Medicines What Is Compounded Tirzepatide &

A 2025 study involving people with sleep apnea found that daytime sleepiness reduced over the 52-week study

If passed, TROA would: Permanently allow Medicare Part D to cover FDA-approved anti-obesity medications Expand Medicare Part B coverage of intensive behavioral therapy for obesity to include a wider range of providers (not just primary care physicians) However, in April 2025, CMS announced it would not include Medicare Part D coverage of obesity drugs in its rule changes for 2026, stating the proposal was "not appropriate at this time." That decision pushed the issue back to Congress, where the TROA remains under consideration

Among firms with 50 or more employees that offer health benefits, 15% have a high-performance network or tiered network as part of their health plan with the largest enrollment in 2025

L-Carnitine 1000mg 90 tablets to support fat metabolism and energy levels